Functional Testing for Glaucoma
Functional Testing for Glaucoma
批准号:
8186451
负责人:
Stuart Gardiner
金额:
$36.45万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2016-06-30
关键词:
AlgorithmsAreaBlindnessClinicalContrast SensitivityDataData CollectionData SetDefectDetectionDiseaseFrequenciesFunctional disorderFutureGlaucomaLaboratoriesLocationMeasurementMeasuresNoiseOptic DiskPatientsPerimetryProbabilityQuality of lifeReportingResearchRetinal Ganglion CellsSourceStimulusStructureTechniquesTestingTimeVisionVisual FieldsVisual system structureWorkbasecentral visual fieldclinical practicecostdesignfollow-upfunctional statusglaucoma testimprovedindexinginstrumentluminancenext generationnovelpreventprognosticresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glaucoma is a leading cause of blindness both in the US and worldwide. The long-term purpose of this project is to improve functional testing in glaucoma. Assessment and follow-up of patients currently relies on automated perimetry to provide functional testing of the visual field. However, the ability to assess progression and/or response to treatment using perimetry is hampered by high variability, especially in areas of moderate or severe glaucomatous damage. Recent findings by our laboratory and others have advanced our understanding of perimetry by challenging key assumptions about the test. This proposal aims to use these advances to explain and reduce the test variability. This will improve the accuracy, efficiency and utility of current functional testing, giving immediate impact in both research and clinical settings, and laying groundwork for the next generation of instruments and algorithms. The first Specific Aim is to produce an accurate and physiologically justified measure of the Effective Dynamic Range (EDR) of perimetry. It is postulated that the very high contrast stimuli used by perimetry in glaucomatous defects saturate the response of the visual system. The resultant nonlinearity in the contrast-response function would cause the detection probability to asymptote below 100%, explaining the high variability in sensitivities in damaged areas. The limit of the EDR will be defined as the contrast beyond which response linearity cannot be assumed. This will be measured by collecting frequency-of-seeing curves in subjects with moderate or advanced glaucoma. The same technique will be used to determine whether the EDR is extended by use of an increased stimulus size. The second Specific Aim is to derive and test a spatial filter to reduce the variability. This will be the first filter to be based both on sensitivities at other locations in the visual field and on the structure of the optic nerve head. The third Specific Aim is to assess the potential utility of using a linear scale for sensitivity, rather than the current logarithmic decibel scale. First, an efficient linear-scaled thresholding algorithm will be derived and tested, to determine whether it will reduce variability both between tests and in the structure-function relation. Second, linear-scaled global indices of the central visual field will be examined, to determine whether they offer improved prognostic value compared with current decibel-scaled indices when assessing progression. The three aims are complementary. It is anticipated that by combining these aims, variability in perimetry will be better understood, and significantly reduced. Such an improvement in a test as commonly performed as perimetry will significantly impact future clinical practice.
PUBLIC HEALTH RELEVANCE: This project aims to explain and reduce the variability observed in functional testing of the visual field in patients with glaucoma. This will allow earlier and more accurate assessment of a patient's current status and response to treatment. It will improve the ability to design an appropriate and cost-efficient personalized management strategy to preserve vision, with the aim of maintaining a patient's quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Testing and Quality of Life in Glaucoma
-
批准号:10734431
-
项目类别:
-
资助金额:$62.8万
-
财政年份:2023
-
负责人:Stuart Gardiner
-
依托单位:
Blood flow and hemodynamics in glaucoma
-
批准号:10701693
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2020
-
负责人:Stuart Gardiner
-
依托单位:
Blood flow and hemodynamics in glaucoma
-
批准号:10031443
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2020
-
负责人:Stuart Gardiner
-
依托单位:
Blood flow and hemodynamics in glaucoma
-
批准号:10254439
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2020
-
负责人:Stuart Gardiner
-
依托单位:
Blood flow and hemodynamics in glaucoma
-
批准号:10470402
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2020
-
负责人:Stuart Gardiner
-
依托单位:
Functional Testing for Glaucoma
-
批准号:8306736
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2011
-
负责人:Stuart Gardiner
-
依托单位:
Functional Testing for Glaucoma
-
批准号:9788453
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2011
-
负责人:Stuart Gardiner
-
依托单位:
Functional Testing for Glaucoma
-
批准号:8500302
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2011
-
负责人:Stuart Gardiner
-
依托单位:
Functional Testing for Glaucoma
-
批准号:10227993
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2011
-
负责人:Stuart Gardiner
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: